Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
--
Revenue (TTM)
--
Net Profit (TTM)
--
ROE
--
ROCE
--
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
EV/EBITDA
--
Div. Yield
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pear Therapeutics Inc. Warrant (PEARW)
| -96.0 | -93.9 | -95.1 | -99.2 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products... include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts. Read more
Founder, Pres, CEO & Director
Dr. Corey M. McCann M.D., Ph.D.
Founder, Pres, CEO & Director
Dr. Corey M. McCann M.D., Ph.D.
Headquarters
Boston, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Pear Therapeutics Inc Warrant (PEARW) is $0.01 (NASDAQ) as of 18-Apr-2023 15:37 EDT. Pear Therapeutics Inc Warrant (PEARW) has given a return of -99.16% in the last 1 years.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-871.55
|
676.50
|
|
2021
|
-4,044.24
|
914.76
|
|
2022
|
-871.55
|
676.50
|
|
2021
|
-4,044.24
|
914.76
|
The 52-week high and low of Pear Therapeutics Inc Warrant (PEARW) are Rs -- and Rs -- as of 05-Apr-2026.
Pear Therapeutics Inc Warrant (PEARW) has a market capitalisation of -- as on 18-Apr-2023. As per SEBI classification, it is a company.
Before investing in Pear Therapeutics Inc Warrant (PEARW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.